Making the Case for Biomarkers in Cancer Treatment
Read how melanoma survivor T.J. Sharpe’s experience on two clinical trials highlights the need for biomarkers to predict benefit from immunotherapy.
Media Type: Html
- SourceUrl: https://www.cancer.gov/publishedcontent/syndication/1127224.htm
- Syndication ID: 19936
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Monday, March 23, 2020 at 07:17 PM
- Date Syndication Updated: Monday, March 23, 2020 at 07:17 PM
Embed Code Snippet
To get the embed code snippet please Login.
